Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report

RATIONALE: Tumor necrosis factor (TNF-α) participates in the pathophysiology of Behcet's disease (BD) and myelodysplastic syndrome (MDS). Infliximab is recommaned for the most severe type of BD, however, there is little evidence for its effectiveness in BD associated MDS. PATIENT CONCERNS: A 46...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yong, Shen, Yan, Ma, Hai-fen, Cai, Jian-Fei, Hua, Yan-qin, Zou, Jun, Guan, Jian-long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815751/
https://www.ncbi.nlm.nih.gov/pubmed/29390339
http://dx.doi.org/10.1097/MD.0000000000009202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815751/
https://www.ncbi.nlm.nih.gov/pubmed/29390339
http://dx.doi.org/10.1097/MD.0000000000009202

Ejemplares similares